Rezolute (RZLT) Non Operating Investment Income (2014 - 2025)
Rezolute's (RZLT) quarterly Non Operating Investment Income came in at -$15000.0 in Q3 2025, little changed year-on-year from -$15000.0 in Q3 2024, and down 150.0% quarter-over-quarter from -$6000.0 in Q1 2025.
Rezolute (RZLT) Non Operating Investment Income (2014 - 2025) Analysis & Trends
Rezolute has disclosed Non Operating Investment Income across 11 years of filings, most recently posting -$15000.0 for Q3 2025.
- Non Operating Investment Income for Q3 2025 came in at -$15000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$21000.0 (up 97.7% YoY), and the FY2024 annual result was -$2.8 million, down 56900.0% from the prior year.
- Non Operating Investment Income came in at -$15000.0 for Q3 2025 at Rezolute, down from -$6000.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $6.6 million in Q2 2022 to a low of -$2.0 million in Q1 2024.
- The 5-year median for Non Operating Investment Income is -$12500.0 (2021), against an average of $300444.4.
- Across the five-year window, Non Operating Investment Income jumped 130960.0% in 2022 and tumbled 13892.86% in 2024, its largest moves.
- Rezolute's Non Operating Investment Income stood at -$12000.0 in 2021, then dropped by 8.33% to -$13000.0 in 2022, then slumped by 38.46% to -$18000.0 in 2023, then jumped by 133.33% to $6000.0 in 2024, then plunged by 350.0% to -$15000.0 in 2025.
- The last three Non Operating Investment Income figures came in at -$15000.0 (Q3 2025), -$6000.0 (Q1 2025), and $6000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 230,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Rezolute | 415.38 Mn | 415.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -15,000.00 |
| Sep 30, 2025 | -15,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Jun 30, 2024 | -900,000.00 |
| Jun 30, 2024 | -900,000.00 |
| Mar 31, 2024 | -1.96 Mn |
| Mar 31, 2024 | -1.96 Mn |
| Dec 31, 2023 | -18,000.00 |
| Dec 31, 2023 | -18,000.00 |
| Sep 30, 2023 | -14,000.00 |
| Sep 30, 2023 | -14,000.00 |
| Jun 30, 2023 | 35,000.00 |
| Jun 30, 2023 | 35,000.00 |
| Mar 31, 2023 | -14,000.00 |
| Mar 31, 2023 | -14,000.00 |